Cargando…
Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder
BACKGROUND: Lithium is the most effective treatment in bipolar disorder. Its use is limited by concerns about risk of chronic kidney disease (CKD). We aimed to develop a model to predict risk of CKD following lithium treatment initiation, by identifying individuals with a high-risk trajectory of kid...
Autores principales: | Hayes, Joseph F., Osborn, David P. J., Francis, Emma, Ambler, Gareth, Tomlinson, Laurie A., Boman, Magnus, Wong, Ian C. K., Geddes, John R., Dalman, Christina, Lewis, Glyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080385/ https://www.ncbi.nlm.nih.gov/pubmed/33906644 http://dx.doi.org/10.1186/s12916-021-01964-z |
Ejemplares similares
-
Childhood and Parental Asthma, Future Risk of Bipolar Disorder and Schizophrenia Spectrum Disorders: A Population-Based Cohort Study
por: Wu, Qiong, et al.
Publicado: (2019) -
A systematic review and meta‐analysis of clinical predictors of lithium response in bipolar disorder
por: Hui, T. P., et al.
Publicado: (2019) -
Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness
por: Hayes, Joseph F., et al.
Publicado: (2019) -
Visual Acuity in Late Adolescence and Future Psychosis Risk in a Cohort of 1 Million Men
por: Hayes, Joseph F, et al.
Publicado: (2019) -
Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden
por: Bauer-Staeb, Clarissa, et al.
Publicado: (2017)